Status:
COMPLETED
Medical Economical Evaluation of the Ablation by Catheter of the Atrial Tissue in the Treatment of AF
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18-79 years
Brief Summary
The atrial fibrillation is the most frequent confusions of the heart rhythm: his preValencia increases with the age, and the investigators consider that beyond 65 years, 5 % of the population is affec...
Detailed Description
The atrial fibrillation is the most frequent confusions of the heart rhythm: his preValencia increases with the age, and we consider that beyond 65 years, 5 % of the population is affected by this arr...
Eligibility Criteria
Inclusion
- Nonspontaneous and ≤90 days) symptomatic and dating of more than 6 months
- Patient in failure of at least 1 antiarrythmic major (Class Ic or amiodarone) or repeats after at least 1 medicamentous or electric reduction
- Patient having presented at least 1 episode of F documented by ECG or Holter
- Patient having a medical history of AF which can be reconstituted retrospectively over the last 12 months
- Patient currently under anticoagulant treatment by AVK balanced
Exclusion
- Patient presenting asymptomatic AF
- Patient presenting AF permanent (90 days)
- Patient presenting a counter-indication at the anticoagulants by oral way
- Patient presenting of the antecedents of ablation of AF
- Patient presenting an intracardiac thrombus
- Patient presenting reversible AF of cause
Key Trial Info
Start Date :
April 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2010
Estimated Enrollment :
503 Patients enrolled
Trial Details
Trial ID
NCT01183091
Start Date
April 1 2005
End Date
October 1 2010
Last Update
September 20 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de cardiologie - Hôpital Lariboisière
Paris, France, 75010